Full name
"SPECJAL-MED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
"SPECJAL-MED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. KILIŃSKIEGO 4, 22-400 ZAMOŚĆ
TAX ID9222686994
Rate company:
"SPECJAL-MED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9222686994
KRS0000211721
Share capital50,000.00 zł
address
UL. KILIŃSKIEGO 4, 22-400 ZAMOŚĆ
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9222686994
REGON
951213656
KRS
0000211721
Legal form
limited liability company
Register Address
UL. KILIŃSKIEGO 4, 22-400 ZAMOŚĆ
Date of registration in KRS
2004-06-30
Date of commencement of economic activity
2004-06-30
Act signature
RDF/626594/24/548
Pkd codes
86.22.Z - Specialist medical practice activities
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
86.1 - Hospital activities
86.2 - Medical and dental practice activities
86.9 - Other human health activities
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets  | 0,4 | 0,5 | 0,6 | 24,2 |
Gross profit (loss) | 0,2 | 0,1 | 0,2 | 23,2 |
EBITDA | 0,2 | 0,1 | 0,2 | 23,2 |
Net profit (loss) | 0,2 | 0,1 | 0,2 | 21,7 |
Cash | 0,3 | 0,3 | 0,4 | 33,6 |
Liabilities and provisions for liabilities | 0,1 | 0,1 | 0,2 | 51,5 |
Net income from sale | 1,1 | 1,4 | 1,7 | 20,3 |
Short time liabilities | 0,1 | 0,1 | 0,2 | 51,5 |
Working assets | 0,4 | 0,5 | 0,6 | 24,2 |
Equity capital | 0,3 | 0,3 | 0,4 | 13,1 |
Operating profit (EBIT) | 0,2 | 0,1 | 0,2 | 23,2 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 56,3 | 41,4 | 44,5 | 3,1 |
Equity capital to total assets | 65 | 71,2 | 64,9 | -6,3 |
Gross profit margin | 14,3 | 10,3 | 10,6 | 0,3 |
EBITDA Margin | 16,2 | 10,3 | 10,6 | 0,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 50 | 34 | 43 | 9 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.